Clinical Trial

Effect and Safety of Non-invasive Electrical Stimulation in Alzheimer's Disease

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
Alzheimer's disease (AD) is the most common neurodegenerative disorder, characterized primarily by cognitive impairment as its main clinical symptom, often accompanied by emotional disturbances such as depression and anxiety, imposing a significant disease burden. Temporal Interference Stimulation (TIS) is an emerging non-invasive electrical stimulation technique that precisely targets deep structures within the hippocampus through interference of multiple electric fields. This study will administer a two-week TIS treatment to patients with AD co-occurring depression, targeting the hippocampus, and compare changes in patients' cognitive function, scores on depression and anxiety scales, and functional magnetic resonance imaging (fMRI) data before and after treatment. An emotional word recall task will be administered during fMRI scans. The aim of this study is to investigate the efficacy, safety, and neural mechanisms of TIS-mediated modulation of hippocampal circuits in improving cognitive and emotional functioning in patients with AD and comorbid depression.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-07-05.
Trial Details
NCT Number NCT07694921
Lead Sponsor First Affiliated Hospital of Zhejiang University
Conditions Alzheimer's Disease(AD)
Enrollment 30 participants
Start Date 2026-06-16
Primary Completion 2027-10-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-27